Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 3, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 6, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000318154-26-000018
Filed / recorded
Mar 6, 2026, 1:38 AM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
AMGEN INC
Issuer CIK
318154
Ticker
AMGN
Reporting person
Nancy A. Grygiel
Relationship
Officer
Officer title
SVP & CCO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Mar 3, 2026
Transaction code
A
Shares / units
2,010
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
9,249
Ownership form
Direct
Amendment
No
Footnotes from the filing
These shares include 110 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.